Package 54092-383-01

{"route": ["ORAL"], "spl_id": "36ca0eef-16f8-46d7-b92b-1aac1f78d70c", "openfda": {"upc": ["0354092387014", "0354092391011"], "unii": ["O1ZPV620O4", "6DPV8NK46S", "G83415V073", "JJ768O327N"], "rxcui": ["861221", "861222", "861223", "861224", "861225", "861226", "861227", "861228", "861232", "861233", "861237", "861238"], "spl_set_id": ["aff45863-ffe1-4d4f-8acf-c7081512a6c0"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-383-01)", "package_ndc": "54092-383-01", "marketing_start_date": "20020522"}], "brand_name": "Adderall XR", "product_id": "54092-383_36ca0eef-16f8-46d7-b92b-1aac1f78d70c", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]"], "product_ndc": "54092-383", "dea_schedule": "CII", "generic_name": "Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate", "labeler_name": "Takeda Pharmaceuticals America, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Adderall", "brand_name_suffix": "XR", "active_ingredients": [{"name": "AMPHETAMINE ASPARTATE MONOHYDRATE", "strength": "2.5 mg/1"}, {"name": "AMPHETAMINE SULFATE", "strength": "2.5 mg/1"}, {"name": "DEXTROAMPHETAMINE SACCHARATE", "strength": "2.5 mg/1"}, {"name": "DEXTROAMPHETAMINE SULFATE", "strength": "2.5 mg/1"}], "application_number": "NDA021303", "marketing_category": "NDA", "marketing_start_date": "20011011", "listing_expiration_date": "20261231"}